High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
On Aug. 26, 2026, a cyberattack halted order processing and shipping at the medical device maker, leaving investors uncertain about the speed of recovery and near-term shipment delays.
Abbott Laboratories has reached a proposed settlement that will see civil penalties paid under the US False Claims Act.
(Updates with DOJ's response in the fifth and sixth paragraphs.) Abbott Laboratories (ABT) will n
Abbott Laboratories (ABT) will not face criminal charges after the US Department of Justice closed a
Some prosecutors believed they had enough to charge Abbott Laboratories, but senior officials opted for civil settlement.
The medical device maker posts fiscal fourth-quarter earnings and revenue that narrowly beat analysts’ estimates.
Investors weigh softer WATCHMAN and urology demand against a still-active device pipeline and capital deployment moves, today, May 27, 2026.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.